Cidel Asset Management’s AbbVie ABBV Stock Holding History

Cidel Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.33M	Buy	9,259 +331	+4%	+$71.2K	0.11%	111
2026 Q1	$1.94M	Buy	8,928 +1,445	+19%	+$321K	0.11%	103
2025 Q4	$1.71M	Sell	7,483 -194	-3%	-$44.2K	0.12%	100
2025 Q3	$1.78M	Buy	7,677 +247	+3%	+$50.3K	0.1%	94
2025 Q2	$1.38M	Buy	7,430 +131	+2%	+$24.3K	0.08%	107
2025 Q1	$1.53M	Buy	7,299 +105	+1%	+$20.4K	0.1%	94
2024 Q4	$1.28M	Buy	7,194 +213	+3%	+$39.2K	0.09%	101
2024 Q3	$1.38M	Hold	6,981	–	–	0.1%	94
2024 Q2	$1.2M	Buy	6,981 +369	+6%	+$61.1K	0.09%	95
2024 Q1	$1.2M	Buy	6,612 +115	+2%	+$19.8K	0.09%	97
2023 Q4	$1.01M	Buy	+6,497	New	+$947K	0.04%	113
2019 Q2	–	Sell	-2,587	Closed	-$208K	–	109
2019 Q1	$208K	Hold	2,587	–	–	0.01%	128
2018 Q4	$239K	Hold	2,587	–	–	0.02%	93
2018 Q3	$245K	Hold	2,587	–	–	0.01%	91
2018 Q2	$240K	Buy	+2,587	New	+$253K	0.01%	92

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cidel Asset Management's ABBV Position: Q2 2026 in Review

Cidel Asset Management increased its AbbVie (ABBV) stake by 3.7% in Q2 2026, buying an estimated $71.2K and bringing the position to 9,259 shares worth $2.33M. The position accounts for 0.11% of the portfolio, ranked #111.

Cidel Asset Management first reported a position in ABBV in Q2 2018 and has held it in 15 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cidel Asset Management held 9,259 shares of AbbVie worth $2.33M as of Q2 2026.
Cidel Asset Management bought 331 AbbVie shares in Q2 2026, an estimated $71.2K.
AbbVie made up 0.11% of Cidel Asset Management's portfolio in Q2 2026, its #111 holding.
Cidel Asset Management first reported a position in AbbVie in Q2 2018 and has held it in 15 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cidel Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.